
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

August 18, 2023
The most common cause for incomplete Phase III trials is enrollment. Indeed, as many as 37% of trials miss...
Read article

April 8, 2022
Robust Trial Design Under Treatment and Enrollment Uncertainty
The planning and optimization of a clinical trial is beset by uncertainties: knowledge of treatment effects, the...
Read article

March 23, 2022
How to Use Historical Data to Mitigate Clinical Trial Risk
For over a decade, the number one reason cited for trial discontinuity has been challenges associated with recruitment...
Read article

February 2, 2022
How to Overcome Common Challenges to Patient Recruitment Projections
For nearly ten years, suboptimal trial enrollment has been cited as a primary cause of clinical trial discontinuation....
Read article

September 5, 2018
Podcast: Enhancing Patient Enrollment Forecasting with EnForeSys 2.0
EnForeSys is Cytel’s tool for patient recruitment planning. We have discussed on the blog recently with Tufts...
Read article

April 13, 2018
Exploring Challenges of Clinical Trial Operations Part 2 with Ken Getz
We return to our discussion with Ken Getz of the Tufts CSDD for part 2 of our blog post on key challenges in clinical...
Read article

April 5, 2018
Ken Getz: Exploring Challenges of Clinical Trial Operations
Photo by J. Kelly Brito on Unsplash Research on clinical trial enrollment makes for sobering reading, characterized by...
Read article
June 4, 2015
Patient Recruitment Feasibility: Would you bet $12 million dollars on it?
Two insightful papers from Applied Clinical Trials should be of interest to many clinical trial planners. The first by...
Read article
April 2, 2015
Monte Carlo Simulations II: Reassessing Strategic Options During an Interim Look
Midway through a trial is a terrible time to realize that you need a new strategy to complete the study. Sadly, it is...
Read article